Science Explorer Back to mapMap
Discussion
Topic · Occupational and environmental lung diseases

Most cited papers in Occupational and environmental lung diseases

Occupational and environmental lung diseases

What are the most cited papers in Occupational and environmental lung diseases?

The most cited paper in Occupational and environmental lung diseases is "Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution" (C. Arden Pope, 2002), with 8,639 citations. Next come "Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015" (7,829) and "Cellular and molecular mechanisms of fibrosis" (4,557).

Showing 50 of 99 papers. Every paper with more than 578 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution C. Arden Pope · JAMA Open access 6 Mar 2002 8,639
2 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Mohammad Hossein Forouzanfar et al. · The Lancet Open access654 authors Oct 2016 7,829
3 Cellular and molecular mechanisms of fibrosis Thomas A. Wynn · The Journal of Pathology Open access 27 Dec 2007 4,557
4 Mechanisms of fibrosis: therapeutic translation for fibrotic disease Thomas A. Wynn, Thirumalai R. Ramalingam · Nature Medicine Open access Jul 2012 3,589
5 Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Nicholas J. Vogelzang, James J. Rusthoven, James Thomas Symanowski et al. · Journal of Clinical Oncology 14 Jul 2003 3,089
6 IARC monographs on the evaluation of carcinogenic risks to humans James C. A. Hopkins · Food and Chemical Toxicology 1989 2,898
7 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Emmanuela E. Gakidou et al. · The Lancet Open access640 authors Sep 2017 2,476
8 Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Victor J. Verwaal, Serge van Ruth, Eelco de Bree et al. · Journal of Clinical Oncology 10 Oct 2003 2,050
9 Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province J. C. Wagner, C. A. Sleggs, P Marchand · Occupational and Environmental Medicine Open access Oct 1960 1,872
10 Passage of Inhaled Particles Into the Blood Circulation in Humans Abderrahim Nemmar, Peter Hoet, B. Vanquickenborne et al. · Circulation Open access 29 Jan 2002 1,719
11 Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE) Ole Raaschou‐Nielsen et al. · The Lancet Oncology Open access 9 Jul 2013 1,614
12 Reduction in Fine Particulate Air Pollution and Mortality Francine Laden, Joel David Schwartz, Frank E. Speizer et al. · American Journal of Respiratory and Critical Care Medicine Open access 19 Jan 2006 1,446
13 Macrophages: Master Regulators of Inflammation and Fibrosis Thomas A. Wynn, Luke Barron · Seminars in Liver Disease Open access 21 Jul 2010 1,412
14 Use of Inhaled Corticosteroids and Risk of Fractures Tjeerd Pieter van Staa, Hubert G. M. Leufkens, Cyrus Cooper · Journal of Bone and Mineral Research Open access Mar 2001 1,314
15 Integrating mechanisms of pulmonary fibrosis Thomas A. Wynn · The Journal of Experimental Medicine Open access 4 Jul 2011 1,298
16 Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients Hans Hellmuth Hirsch, Wendy A. Knowles, Michael Dickenmann et al. · New England Journal of Medicine Open access 15 Aug 2002 1,227
17 First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial Paul Baas et al. · The Lancet Open access 2021 1,226
18 Silicosis Chi Chiu Leung, Ignatius Tak Sun Yu, Weihong Chen · The Lancet 23 Apr 2012 1,223
19 Statistical software for analyzing the health effects of multiple concurrent exposures via Bayesian kernel machine regression Jennifer F. Bobb, Birgit Claus Henn, Linda Valeri et al. · Environmental Health Open access 20 Aug 2018 1,122
20 Germline BAP1 mutations predispose to malignant mesothelioma Joseph R. Testa, Mitchell Cheung, Jianming Pei et al. · Nature Genetics Open access 28 Aug 2011 1,088
21 Advances in Malignant Mesothelioma Bruce W.S. Robinson, Richard Lake · New England Journal of Medicine 12 Oct 2005 1,077
22 Epidemiology of Lung Cancer Anthony J. Alberg, Jonathan M. Samet · Elsevier eBooks Book chapter 2010 1,064
23 Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis Ghassan Badri Hamra, Neela Guha, Aaron Cohen et al. · Environmental Health Perspectives ReviewOpen access 6 Jun 2014 1,039
24 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer Victor J. Verwaal, Sjoerd C. Bruin, Henk Boot et al. · Annals of Surgical Oncology 2 Jun 2008 1,039
25 Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells Miroslav Stýblo, Luz María Del Razo, Libia Vega et al. · Archives of Toxicology 18 Aug 2000 998
26 Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients David J. Sugarbaker, Raja Michael Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery Open access 1999 990
27 Mechanisms in the Pathogenesis of Asbestosis and Silicosis Brooke T. Mossman, Andrew Churg · American Journal of Respiratory and Critical Care Medicine May 1998 987
28 Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial Gérard Zalcman et al. · The Lancet 22 Dec 2015 980
29 Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis Roderick J. Phillips, Marie D. Burdick, Kurt M. Hong et al. · Journal of Clinical Investigation Open access Aug 2004 958
30 Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations Raphael Bueno et al. · Nature Genetics 29 Feb 2016 947
31 Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 Chun Geun Lee, Robert Homer, Zhou Zhu et al. · The Journal of Experimental Medicine Open access 17 Sep 2001 944
32 Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis Bice Fubini, Andrea K. Hubbard · Free Radical Biology and Medicine 24 Apr 2003 941
33 A review of human carcinogens—Part C: metals, arsenic, dusts, and fibres Kurt Straíf, Lamia Benbrahim‐Tallaa, Robert A. Baan et al. · The Lancet Oncology May 2009 923
34 The Nalp3 inflammasome is essential for the development of silicosis Suzanne L. Cassel, Stephanie C. Eisenbarth, Shankar S. Iyer et al. · Proceedings of the National Academy of Sciences Open access 24 Jun 2008 922
35 Oesophageal squamous cell carcinoma: I. A critical review of surgery Richard Earlam, J R Cunha-Melo · British journal of surgery Jun 1980 909
36 Asbestos, carbon nanotubes and the pleural mesothelium: a review and the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma Ken Donaldson, Fiona A Murphy, Rodger Duffin et al. · Particle and Fibre Toxicology Open access 2010 906
37 The European mesothelioma epidemic Julian Peto, Adriano Decarli, Carlo La Vecchia et al. · British Journal of Cancer Open access 14 Jan 1999 903
38 Adult-onset pulmonary fibrosis caused by mutations in telomerase Kalliopi Tsakiri, Jennifer T. Cronkhite, Phillip J. Kuan et al. · Proceedings of the National Academy of Sciences Open access 26 Apr 2007 899
39 Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains Carmine Carpenito, Michael C. Milone, Raffit Hassan et al. · Proceedings of the National Academy of Sciences Open access 11 Feb 2009 896
40 Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 Mark Roberts, E Neville, Richard G Berrisford et al. · Thorax Open access Aug 2010 893
41 Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Gavin J. Gordon, Roderick V. Jensen, Li-Li Hsiao et al. · PubMed Sep 2002 882
42 Pathogenesis of Idiopathic Pulmonary Fibrosis Paul J. Wolters, Harold R. Collard, Kirk D. Jones · Annual Review of Pathology Mechanisms of Disease ReviewOpen access 20 Sep 2013 881
43 Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin Dominique M. Elias, Jérémie H. Lefèvre, Julie Chevalier et al. · Journal of Clinical Oncology 22 Dec 2008 874
44 Standardized Quantification of Pulmonary Fibrosis in Histological Samples Ralf‐Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari et al. · BioTechniques Open access Apr 2008 853
45 Employment and work-related issues in cancer survivors Anja Mehnert · Critical Reviews in Oncology/Hematology 9 Feb 2010 847
46 Pulmonary fibrosis: pathogenesis, etiology and regulation Mark S. Wilson, Thomas A. Wynn · Mucosal Immunology Open access 7 Jan 2009 842
47 Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression Fei Liu, Justin D. Mih, Barry S. Shea et al. · The Journal of Cell Biology Open access 23 Aug 2010 839
48 Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube Atsuya Takagi, Akihiko Hirose, Tetsuji Nishimura et al. · The Journal of Toxicological Sciences 2008 837
49 Mechanisms of Pulmonary Fibrosis Victor John Thannickal, Galen B. Toews, Eric S. White et al. · Annual Review of Medicine Review 27 Jan 2004 835
50 TGF-β1 Signaling and Tissue Fibrosis Kevin K. Kim, Dean Sheppard, Harold A. Chapman · Cold Spring Harbor Perspectives in Biology Open access 21 Apr 2017 815

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.